SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Healthcare >

Gilead Sciences, Inc. (GILD)

GILD RSS Feed
Add GILD Price Alert      Hide Sticky   Hide Intro
Moderator: mick, DewDiligence, wshaw14
Search This Board: 
Last Post: 7/27/2017 12:40:58 PM - Followers: 107 - Board type: Free - Posts Today: 0


GILD Investor Relations

http://www.otcmarkets.com/stock/GILD/quote
http://www.otcmarkets.com/stock/GILD/profile
Contact Info
  • 333 Lakeside Drive
    Foster City, CA 94404
GILD Security Details
Share Structure
  Market Value1 $94,343,029,244 a/o Dec 30, 2016
  Authorized Shares Not Available
  Outstanding Shares 1,317,456,071 a/o Oct 31, 2016
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float Not Available
  Par Value 0.001
Transfer Agent(s)
BNYMellon Shareowner Services
Shareholders
Shareholders of Record 363 a/o Feb 24, 2016
Corporate Actions
  Ex. Date Record Date Pay Date
Dividend (0.47) Dec 13, 2016 Dec 15, 2016 Dec 29, 2016
Dividend (0.47) Sep 14, 2016 Sep 16, 2016 Sep 29, 2016
Dividend (0.47) Jun 14, 2016 Jun 16, 2016 Jun 29, 2016
 
Dividends are not adjusted for stock splits
Security Notes
  • Capital Change=shs increased by 2 for 1 split. Ex-date=03/08/2002. Rec date=02/14/2002. Pay date=03/07/2002.
    Latest Addt'l Issue=2-96 4,000,000 shs at $37.75 by Robertson, Stephens & Co. et al.
    New Issue=1-92 5,000,000 shs at $15 by Robertson, Stephens & Co., et al.
    Capital Change=shs increased by 2 for 1 split. Ex-date=02/22/2001. Rec date=02/02/2001. Pay date=02/21/2001.
    Capital Change=shs increased by 2 for 1 split. Ex-date=09/07/2004. Rec date=08/12/2004. Pay date=09/03/2004.
    Capital Change=shs increased by 2 for 1 split Ex-date=06/25/2007. Rec date=05/24/2007. Pay date=06/22/2007.
    Capital Change=shs increased by 2 for 1 split. Ex-date=01/28/2013. Rec date=01/07/2013. Pay date=01/25/2013.

    http://finviz.com/quote.ashx?t=GILD&ty=c&ta=1&p=d
    http://finviz.com/ ;



  •  
***DISCLAIMER***
-  The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
-  We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
-  There are no guarantees when buying or selling any security.









     
 
Short Selling Data
Short Interest 19,440,457 (-7.51%)
Nov 30, 2010
Significant Failures to Deliver No


 
GILD
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GILD News: European Commission Grants Marketing Authorization for Gilead’s Vosevi® (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Trea... 05:46 AM
GILD News: Current Report Filing (8-k) 07/26/2017 04:05:30 PM
GILD News: Gilead Sciences Announces Third Quarter 2017 Dividend 07/26/2017 04:02:00 PM
GILD News: Gilead Sciences Announces Second Quarter 2017 Financial Results 07/26/2017 04:01:00 PM
GILD News: Statement of Changes in Beneficial Ownership (4) 07/25/2017 06:54:22 PM
News News Alert: European Commission Grants Marketing Authorization for Gilead’s Vosevi® (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Trea... 07/28/2017 05:46:00 AM
PostSubject
#2620  Sticky Note GILD reports 2Q17 results—$2.9B HCV sales beat consensus forecast: DewDiligence 07/26/17 04:08:22 PM
#2444  Sticky Note After tough year, 9 questions for Gilead mick 01/03/17 02:27:26 PM
#2622   Transcript of GILD’s 2Q17 CC: DewDiligence 07/27/17 12:40:58 PM
#2621   I try not to watch my big boys fink 07/27/17 09:52:17 AM
#2620   GILD reports 2Q17 results—$2.9B HCV sales beat consensus forecast: DewDiligence 07/26/17 04:08:22 PM
#2619   https://seekingalpha.com/article/4090165-gilead-puts-good-fight Inoviorulez 07/25/17 07:08:50 PM
#2618   https://seekingalpha.com/article/4089210-gilead-another-ace-sleeve Inoviorulez 07/20/17 08:36:24 PM
#2617   Vosevi’s US list price leaves ample room for DewDiligence 07/19/17 11:10:47 AM
#2616   07/18/2018 FDA approves Vosevi for Hepatitis C wshaw14 07/18/17 02:50:05 PM
#2615   Gilead Sciences, Inc (GILD) mick 07/12/17 08:36:34 AM
#2614   https://www.healio.com/ophthalmology/retina-vitreous/news/online/%7Bc292f741-834 wshaw14 07/07/17 12:01:03 AM
#2613   Yes Sir, my 50K shares are finally green. WAR_CTR4Hire 06/27/17 02:41:57 PM
#2612   War, CYDY looking very strong this week! PNW_Ironman 06/27/17 02:13:51 PM
#2611   Gilead should keep the momentum going and either WAR_CTR4Hire 06/23/17 10:19:56 AM
#2610   GILD's PR on Vosevi (f/k/a/ SOF/VEL/VOX) CHMP approval: DewDiligence 06/23/17 10:05:32 AM
#2609   Thanks DD. A great piece of info I missed. wshaw14 06/22/17 10:32:15 PM
#2608   Gilead should keep the momentum going and either PNW_Ironman 06/22/17 04:13:29 PM
#2607   GILD prevails against MRK in Sovaldi ruling: #msg-132407407. DewDiligence 06/22/17 11:54:15 AM
#2606   Detailed Quote for Gilead Sciences Inc. (GILD) mick 06/19/17 06:19:14 PM
#2605   Just checked the GILD site and see they shub 06/15/17 03:21:17 PM
#2604   GILD submits NDA for Bictegravir-based FDC: DewDiligence 06/12/17 09:47:16 AM
#2603   right oil pipeline it going to lower pps mick 06/10/17 08:32:24 PM
#2602   July 4th is my evaluation date. fink 06/10/17 08:05:48 PM
#2601   http://www.barchart.com/interactive_charts/stocks/GILD mick 06/10/17 07:52:01 PM
#2600   been said cash cow, activist will checkin. $GILD mick 06/10/17 07:51:33 PM
#2599   contact to mayday $GILD mick 06/10/17 07:49:56 PM
#2598   Hero to zero stock. fink 06/10/17 07:47:21 PM
#2597   GILD News: Amended Current Report Filing (8-k/a) 05/18/2017 04:09:24 PM mick 05/24/17 08:37:19 AM
#2596   Gilead Sciences, Inc (GILD) mick 05/24/17 08:37:13 AM
#2595   FDA Seems to Back Pill to Help Prevent HIV wshaw14 05/15/17 01:38:41 AM
#2594   GILD reports 1Q17 results: DewDiligence 05/02/17 04:30:00 PM
#2593   This Is Why Investors Should Be Bullish Into ITMS 05/02/17 02:13:06 PM
#2592   TURNING GOLDEN ????? stockcharts.com/c-sc/sc?s=GILD&p=D&yr=5&mn=0&dy=0&i= mick 04/28/17 10:45:34 AM
#2591   I believe this is in GILDs pipeline. https://www.sciencedaily.com/releases/2017 wshaw14 04/27/17 04:27:52 PM
#2590   JNJ/ACHN’s 3-DAA HCV regimen has a problem: #msg-130712374. DewDiligence 04/22/17 11:58:59 AM
#2589   Gilead Announces Positive Proof-of-Concept Data for its NASH Candidate wshaw14 04/21/17 04:15:10 PM
#2588   Just went long here for first time in common_cents 04/21/17 02:08:20 PM
#2587   Gilead Presents Data at the International Liver Congress™ wshaw14 04/21/17 04:35:50 AM
#2586   Gilead to Present Clinical and Preclinical Data on wshaw14 04/21/17 04:32:07 AM
#2585   RSI looking to drop below the current 33 Couch 04/11/17 09:51:56 PM
#2584   See Why I Am Buying Gilead Sciences $GILD Here ITMS 04/11/17 03:13:30 PM
#2583   Gilead Sciences, Inc (GILD) mick 04/07/17 11:10:34 PM
#2582   FDA Approves Two Hepatitis C Drugs - Sovaldi wshaw14 04/07/17 10:46:23 PM
#2581   EPCLUSA™ - Alberta Also Broadens Access for Patients wshaw14 04/03/17 10:43:52 PM
#2580   GILD News: British Columbia lists EPCLUSA™ on public mick 03/25/17 08:26:07 PM
#2579   Gilead Sciences, Inc (GILD) mick 03/25/17 08:26:00 PM
#2578   What's the deal with the sp why is 123boom 03/24/17 04:29:35 PM
#2577   Thanks for the info. I will leave all wshaw14 03/24/17 04:16:45 PM
#2576   Kite's methodology still has some very serious shortcomings..It's shub 03/24/17 03:08:53 PM
#2575   I have not seen any rumors on that wshaw14 03/20/17 07:43:54 PM
#2574   Rumors on INCYTE and Kite..Nothing on CYDY!Y pearsby09 03/20/17 06:32:12 PM
#2573   I have also been seeing rumors about GILD wshaw14 03/17/17 04:20:56 PM
PostSubject